Chrissy Metz says a GLP-1 has made Broadway prep easier. She says the medication has really minimized her inflammation and given her more mental room than she had before.
Over the weekend, the 45-year-old spoke at the Nocturne premiere in a green velvet gown and said, “I think, honestly, being able to run around a stage eight shows a week was like really, really amazing,” to ET. She added, “I’m perimenopausal, I got knee issues, there’s things going on,” which makes the physical side of & Juliet more than a vanity project.
Nocturne carpet, Broadway load
Eight shows a week is the real workload here. Metz is preparing for her Broadway debut in & Juliet, and her comments put the medication in a functional frame: less inflammation, less distraction, more capacity for the demands of a stage schedule that does not leave much room for hesitation.
She also said the GLP-1 has helped with “the mental capacity to have other things to think about than obsessing about the food noise, that’s been super, super helpful. It’s been great.” That is a different claim than the usual weight-loss talking point. She is describing a day-to-day benefit tied to focus, appetite chatter, and the physical grind of performance.
April 2025 and August
The timeline matters because Metz had said in April 2025 that she lost 100 pounds thanks to strength training. In August, she said on her Instagram Story that she was making progress on the strength training journey, then revealed she was taking a GLP-1 after losing 100 pounds last year. The sequence leaves a useful distinction in place: the weight loss was tied publicly to training first, and the medication came into view later as part of what she says helps now.
She had also said in April 2025 that it was important to destigmatize anything when asked about Ozempic, and she told People that her experience with the medication was great after years of ineffective diets. Her latest comments do not erase that earlier framing; they complicate it, and that is the more useful story for readers. Metz is not selling a miracle. She is describing a tool that, for her, appears to make stage work and daily life easier while she gets ready for & Juliet.
GLP-1 without a name
What she has not named is the specific GLP-1 she is using. For readers who are trying to understand her update, that is the one missing detail that would turn a broad medication category into a clearer personal report, and she has not supplied it yet.
